Stack Archive · Specialized Directory

Biohacking

Data-driven physiological optimization — wearables, protocols, and the clinical research behind what actually moves your biomarkers.

182analyses
3blueprints
Oct 16updated
Latest Analysis 182All analysis →

Medtronic and Corsano Are Building the Hospital-to-Home Wearable Stack

Medtronic's integration of Corsano's FDA-cleared multi-parameter wearable into its HealthCast platform extends clinical monitoring from pre-op through home recovery — targeting alarm fatigue along the way.

· 2 min

C15:0: The Saturated Fat That Longevity Researchers Are Rethinking

Pentadecanoic acid — an odd-chain saturated fatty acid — is showing geroprotective properties that challenge blanket warnings against saturated fat, with initial research from Navy dolphin aging studies.

· 2 min

SystemAge 2.1: The First Biological Age Test with Separate Male and Female Models

Generation Lab's SystemAge 2.1 analyzes 460+ biomarkers across 21 organ systems using gender-specific algorithms — the most granular biological age measurement now available through clinical partners.

· 3 min

GARM's Klotho Longevity Residency Brought 22 Participants to Honduras. Here's What They're Testing.

A four-day longevity residency at the Kimpton Grand Roatán included a proprietary Klotho intervention, blood sampling before and after, and researchers from MIT and Harvard. GARM is betting that Klotho is the next longevity biomarker to watch.

· 4 min

Peter Attia: High HDL Cholesterol Doesn't Protect Your Heart. It Might Hurt It.

HDL-C has been called 'good cholesterol' for decades. Peter Attia's latest analysis unpacks why the clinical evidence never supported the label — and why very high HDL-C levels may signal elevated cardiovascular risk, not lower.

· 3 min

Lung Cancer Screening for Never-Smokers: What the Data Says

Guidelines don't recommend lung cancer screening for never-smokers — but the evidence gap is a policy artifact, not a scientific finding. Peter Attia makes the case for personalized assessment.

· 2 min

Rapalogix: $20M to Bring Rapamycin Anti-Aging Science to Skincare

Rapalogix Health raised a $20M Series A to expand rapamycin-based skincare targeting TORC1 — the cellular pathway behind systemic longevity interventions, now applied topically.

· 2 min

Menopause Tracking: Why the Average Is 9 Symptoms, Not 1 or 2

A Winona study of 100,000+ women found an average of nine simultaneous menopause symptoms — and 77.5% waited over a year before accessing care. The data reframes how practitioners should think about this life stage.

· 3 min

Your Complete Genome for $599: Human Longevity Inc. Bets on Consumer Genomics

Human Longevity Inc. now offers full whole-genome sequencing for $599 — down from ~$10,000 a decade ago — bundled with AI-powered multi-omics analysis across more than 50,000 conditions.

· 3 min

Ultrahuman M2 Live Makes Continuous Glucose Monitoring Mainstream

Ultrahuman's M2 Live pairs with Abbott's OTC Lingo CGM to bring prescription-free glucose tracking to anyone for $99/month — removing the biggest barrier to metabolic health monitoring.

· 3 min

Beacon Biosignals: AI Sleep Staging Is Moving Out of the Lab

Beacon Biosignals presented clinical validation data for its AI sleep staging algorithms at SLEEP 2026. What their EEG foundation model means for where consumer sleep tech is headed.

· 2 min

Nuritas' AI-Discovered Peptides Are Now in Frozen Yogurt — and 31 Countries

Nuritas uses AI to discover functional peptides from plant proteins, then validates them through clinical research. At IFT FIRST 2026, PeptiStrong arrived in frozen yogurt format. What this means for functional nutrition.

· 2 min

Why Smart People Believe Bad Health Advice: The Cognitive Bias Map

Intelligence doesn't protect against health misinformation — it often amplifies it. Here's the framework for recognizing which cognitive traps are most likely to corrupt your health decision-making.

· 4 min

Clair Raises $11.6M to Build the First Continuous Hormone Monitor for Women

Clair's wrist-worn device uses 10 biosensors and 130+ proprietary biomarkers to infer estrogen, progesterone, LH, and FSH levels in real time — revealing 9 distinct hormonal sub-phases the traditional 4-phase model misses.

· 3 min

Forever Chemicals Are Accelerating Your Biological Age — Longevity Needs to Catch Up

Two peer-reviewed studies link PFAS exposure to accelerated epigenetic aging via C-reactive protein. The longevity field's focus on what to add ignores what to remove — and that gap is measurable.

· 3 min

Elysium Creatine+: A Three-Ingredient Stack Targeting Strength, Recovery, and Longevity

Elysium Health's new Creatine+ combines creatine monohydrate with HMB and pomegranate-derived urolithin A precursors — a longevity-focused formulation co-developed with a Stanford longevity researcher.

· 2 min

Sky Labs' CART BP Pro Ring Heads to Europe After 260K+ South Korean Prescriptions

Sky Labs is launching its cuffless blood pressure monitoring ring in Europe and the UK, backed by CE-MDR certification and a 260,000+ prescription track record in South Korea.

· 3 min

Geroscience Is Rewriting the Logic of Disease Prevention

Thirty percent of centenarians escape major age-related disease entirely — not by treating conditions as they arrive, but by aging differently. Geroscience targets the shared biological mechanisms underlying multiple diseases simultaneously. Here's where the clinical evidence stands in 2026.

· 4 min

The Breast Cancer Screening Framework Peter Attia Uses — And Why Standard Mammogram Advice Falls Short

Risk-stratified screening starts with a formal risk assessment by age 25 — not when your doctor first orders a mammogram at 40. Peter Attia's framework explains why, and what the implementation failure actually looks like at scale.

· 2 min

The World's First Human Kidney Regeneration Surgery Is Scheduled for July 2026

Rokit Healthcare has clinical approval to begin the first human kidney regeneration trial using AI-assisted 3D bioprinting and robotic surgery with the patient's own omentum-derived cells — a milestone that sidesteps transplant waiting lists entirely.

· 2 min

China Launches the World's First 2,000-Person Stem Cell Antiaging Trial

Beijing's 301 Hospital is running the largest stem cell trial ever attempted for aging prevention, shifting longevity science from disease treatment toward systemic intervention.

· 2 min

Immorta Bio's Combination Therapy Reports 70%+ Lifespan Extension in Animal Models

A peer-reviewed study combining senolytic immunotherapy with stem cell regeneration shows dramatic lifespan gains. What the animal data does and doesn't tell us.

· 2 min

Evipedia: 500+ Longevity Interventions, One Evidence Standard

The Forever Healthy Foundation's Evipedia organizes longevity science across 500+ interventions using AI-assisted audit-based reviews — a practical research tool for practitioners navigating the evidence problem.

· 3 min

Longevity Tourism: A Practical Guide to Health Destination Travel in 2026

From $899 MRI screenings to $85K concierge memberships — a framework for evaluating longevity travel destinations, what each protocol tier actually delivers, and how to calibrate spend against evidence quality.

· 2 min

Newsletter coming soon.

Curated digests across AI, biohacking, photography, travel, and more. Be the first to know when we launch.